Suchergebnisse - "Lenalidomide"

PubPharm (5.934)

91

Detection of lenalidomide metabolites in urine to discover drug-resistant compounds

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2024

von Zhan, X. | Liu, X. | Rang, L. | +9

92

Near-infrared light controlled protein degradation by photo-caged lenalidomide and pomalidomide

enthalten in: Bioorganic chemistry | 2024

von Zhu, Y. | Yan, X. | Shi, Y. | +3

93

Complete Remission in a TEMPI Syndrome Treated with a Daratumumab, Lenalidomide, and Dexamethasone-Based Regimen : A Case Report

enthalten in: Case reports in oncology | 2024

von Sansen, P. | Montfort, L. | Nanquette, A. | +2

94

Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma

enthalten in: Pathogens (Basel, Switzerland) | 2024

von Yeşilaltay, A. | Muz, D. | Erdal, B. | +6

95

Progression-Free Survival of Daratumumab Versus Bortezomib Triplet Combination With Lenalidomide and Dexamethasone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma : TAURUS Chart Review Study

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Gordan, L. | Tan, C. | Vescio, R. | +12

96

Multiple myeloma with IgH::MYC and multiple extramedullary lesions

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2024

von Sasaki, Y. | Ichikawa, S. | Sakurai, K. | +7

97

Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma

enthalten in: Blood cancer discovery | 2024

von Welsh, S. | Barwick, B. | Meermeier, E. | +30

CommentIn: Blood Cancer Discov. 2024 Jan 8;5(1):5-7. - PMID 38085608

98

Peripheral blood stem cell mobilisation following bortezomib, lenalidomide and dexamethasone induction for multiple myeloma : a real-world single-centre experience

enthalten in: Internal medicine journal | 2024

von Sim, S. | Quach, H. | Pham, T. | +2

99

Association of proton pump inhibitor use with survival and adverse effects outcomes in patients with multiple myeloma : pooled analysis of three clinical trials

enthalten in: Scientific reports | 2024

von Almansour, S. | Alqudah, M. | Abuhelwa, Z. | +8

100

A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients : a report from the Triveneto Myeloma Working Group

enthalten in: Annals of hematology | 2024

von Barilà, G. | Quaglia, F. | Furlan, A. | +21